Estadístiques de Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial
Visites totals
views | |
---|---|
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial | 124 |
Visites totals per mes
views | |
---|---|
October 2024 | 0 |
November 2024 | 2 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
Visites al fitxer
views | |
---|---|
alba_brjcan_trast.pdf(legacy) | 64 |
alba_brjcan_trast.pdf | 42 |
Vistes principals per país
views | |
---|---|
United States | 89 |
Spain | 8 |
Sweden | 8 |
Ireland | 5 |
Belgium | 3 |
Germany | 2 |
Iran | 2 |
Australia | 1 |
Belarus | 1 |
China | 1 |
France | 1 |
India | 1 |
Russia | 1 |
Visites principals per ciutat
views | |
---|---|
San Ramon | 19 |
Boardman | 11 |
Mountain View | 10 |
Fairfield | 9 |
Ann Arbor | 6 |
Dublin | 5 |
Ashburn | 4 |
Menlo Park | 4 |
Cambridge | 3 |
Erlangen | 2 |
Las Rozas De Madrid | 2 |
Cabañaquinta | 1 |
Las Palmas | 1 |
Portland | 1 |
Rochester | 1 |
Roquetas De Mar | 1 |
Sacramento | 1 |
San Diego | 1 |
Shenzhen | 1 |
Thane | 1 |
Vitebsk | 1 |
West Bloomfield | 1 |